Arkema S.A. (OTCMKTS:ARKAY – Get Free Report) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 6,400 shares, a growth of 255.6% from the October 31st total of 1,800 shares. Based on an average daily volume of 28,200 shares, the short-interest ratio is presently 0.2 days.
Arkema Stock Down 1.8 %
OTCMKTS ARKAY traded down $1.41 during trading hours on Wednesday, reaching $77.64. 22,157 shares of the company’s stock traded hands, compared to its average volume of 16,719. Arkema has a 52-week low of $76.21 and a 52-week high of $114.15. The firm has a market cap of $5.91 billion, a PE ratio of 8.81, a PEG ratio of 0.46 and a beta of 1.27. The firm has a 50-day simple moving average of $88.63 and a 200 day simple moving average of $91.21. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.86 and a quick ratio of 1.38.
Arkema (OTCMKTS:ARKAY – Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter. Arkema had a net margin of 3.82% and a return on equity of 7.99%. The company had revenue of $2.63 billion during the quarter. Sell-side analysts anticipate that Arkema will post 9.05 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Arkema
About Arkema
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Further Reading
- Five stocks we like better than Arkema
- What is a support level?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Warren Buffett Stocks to Buy Now
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.